The significance of chlamydia trachomatis in urethritis and prostatitis - Differences in therapeutic approach - Croatian experience

Journal of Chemotherapy

Volumn 21, Issue 1, 2009, Pages 63-67

  Škerk, Višnja ^a   Markovinovic L ^a   Zekan, S ^a   Jaksic J ^b   Lepej, S Židovec ^a   Markotic A ^a   Škerk, Vedrana ^a   Radosevic V ^c   Cvitkovic L ^b   Begovac, J ^a  

^a Croatia   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Azithromycin; Chlamydia trachomatis; Prostatitis; Treatment; Urethritis

Indexed keywords

AZITHROMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL URETHRITIS; CHRONIC PROSTATITIS; CONTROLLED STUDY; CROATIA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG INDICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; MYCOPLASMA HOMINIS; PATHOGENESIS; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; UREAPLASMA UREALYTICUM; URETHRITIS;

EID: 63049131826     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.1.63     Document Type: Article

References (16)

1. Stamm WE, Jones RB, Batteiger BE. Chlamydia trachomatis. In: Mandell GL, Bennett JE, Dolin R, ed. Principles and practice of infectious diseases. 6th ed. London: Churchill Livingstone; 2005: 2240-54.
2. Pechere JC, ed. Intracellular bacterial infections. Cambridge: Medical Publications; 1996: 59-64.
3. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996;276:1737-42.
4. Gomberg M. Persistent Chlamydial Infection. Medicus 2003;12:179-88.
5. Epidemiology Service. Croatian National Institute of Public Health. http://www.hzjz.hr/
6. Škerk V, Čajić V, Markovinović L, et al. Etiology of chronic prostatitis syndrome in patients treated at the University Hospital for Infectious Diseases "Dr. Fran Mihaljević" from 2003 to 2005. Coll Antropol 2006;30 (Suppl 2):145-9.
7. Škerk V, Krhen I, Schönwald S, et al. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004;24 (Suppl 1):S53-6.
8. Hiršl-Hećej V, Pustišek N, Šikanić-Dugić N, Domljan LM, Kani D. Prevalence of chlamydial genital infection and associated risk factors in adolescent females at an urban reproductive health care center in Croatia. Coll Antropol 2006;30 (Suppl.2):131-7.
9. Hiršl-Hećej V, Šikanić-Dugić N, Domljan LM, Pustišek N, Kani D, Žele-Starčević L. Chlamydia trachomatis in adolescents and young women. 9th Symposium on sexually transmitted diseases and urogenital infections. Opatija, March 17-19, 2007. Abstract book, p.40-1.
10. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55(RR-11):1-94.
11. Škerk V, Krhen I, Francetić I, Baršić B, Vrćić H. New view on treatment of sexually transmitted diseases with azithromycin. Medicus 2004;13:247-53.
12. Škerk V. Treatment of sexually transmitted infections. PLIVA ućilište Glasnik 2008;(26):1-4.
13. Škerk V, Schönwald S, Krhen I, et al. Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2001; 13: 664-5.
14. Škerk V, Krhen I, Lisić M, et al. Azithromycin: 4.5- or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis-a randomized study. J Chemother 2004; 16: 408-10.
15. Magri V, Trinchieri A, Ceriani I, Marras E, Perletti G. Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome. Arch Ital Urol Androl 2007; 79: 93-8.
16. Magri V, Trinchieri A, Pozzi G, et al. Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis. Int J Antimicrob Agents 2007; 29: 549-56.